Physico-chemical characteristics of drugs and excipients: An overview

American Pharmaceutical Review

Volumn 9, Issue 2, 2006, Pages

  Ahmed, Salah U ^a   Naini, Venkatesh ^a   Vaithiyalingam, Sivakumar R ^a  

^a Research and Development

Author keywords

[No Author keywords available]

Indexed keywords

EXCIPIENT; RITONAVIR;

DRUG ABSORPTION; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG STRUCTURE; PHYSICAL CHEMISTRY; QUALITY CONTROL; REVIEW;

EID: 34248342747     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. R.L. Friedman, Continuous Improvement Under Modern Quality Systems and cGMPs, CDER, Office of Compliance, Division of Manufacturing & Product Quality, www.fda.gov/cder/present/DIA2005/Friedman.pdf, 2005.
2. METHOCEL Cellulose Ethers Technical Handbook, Dow Chemical Company, 2005.
3. X-ray Crystallography. In Solid State Chemistry of Drugs, Second Edition, S. R. Byrn, R. R. Pfeiffer and J. G. Stowell, SSCI, West Lafayatte, 1999.
4. J.H. Hildebrand and R.L. Scott. Solubility of Nonelectrolytes, Dover, New York, 1964.
5. Using METHOCEL Cellulose Ethers for Controlled Release of Drugs in Hydrophilic Matrix Systems. Dow Chemical Company, 2005.
6. S. L. Morissette, S. Soukasene, D. Levinson, M. J. Cima and O. Almarrsson. Elucidation of Crystal Form Diversity of the HIV Protease Inhibitor Ritonavir by High-throughput Crystallization. Proc. Natl. Acad. Sci. (PNAS), 100(5), 2003, 2180-2184.
7. http://www.fda.gov/cder/drug/infopage/palladone/default.htm; CDER, Rockville, MD, 2005.
8. Quality Systems Approach to Pharmaceutical Good Manufacturing Practices, Draft Guidance, CDER, Rockville, MD, 2004.
9. PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance. Guidance for Industry, CDER, Rockville, MD, 2004.